Monimoi Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Monimoi Therapeutics General Information

Description

Developer of transformative therapies intended to harness the potential of covalent medicines and chemical proteomics. The company develops chemical proteins, innovative molecular technology with deep human translational insights for potential drug targets, enabling medical professionals to get the required support in developing drugs that target cancer-promoting proteins and innovate advanced treatments for cancer patients.

Contact Information

Website
www.monimoitx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 40 Guest Street, Brighton
  • Boston, MA 02135
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 40 Guest Street, Brighton
  • Boston, MA 02135
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Monimoi Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2026 Completed Startup
To view Monimoi Therapeutics’s complete valuation and funding history, request access »

Monimoi Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Monimoi Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Catalio Capital Management Venture Capital Minority
Mass General Brigham Ventures Venture Capital Minority
Ono Venture Investment Corporate Venture Capital Minority
Regeneron Ventures Corporate Venture Capital Minority
The Column Group Venture Capital Minority
To view Monimoi Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Monimoi Therapeutics FAQs

  • When was Monimoi Therapeutics founded?

    Monimoi Therapeutics was founded in 2025.

  • Where is Monimoi Therapeutics headquartered?

    Monimoi Therapeutics is headquartered in Boston, MA.

  • What is the size of Monimoi Therapeutics?

    Monimoi Therapeutics has 13 total employees.

  • What industry is Monimoi Therapeutics in?

    Monimoi Therapeutics’s primary industry is Drug Discovery.

  • Is Monimoi Therapeutics a private or public company?

    Monimoi Therapeutics is a Private company.

  • What is Monimoi Therapeutics’s current revenue?

    The current revenue for Monimoi Therapeutics is .

  • Who are Monimoi Therapeutics’s investors?

    Catalio Capital Management, Mass General Brigham Ventures, Ono Venture Investment, Regeneron Ventures, and The Column Group have invested in Monimoi Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process